Sanofi diabetes drug awaits imminent EU green light

By Ben Hirschler LONDON (Reuters) – Sanofi’s new Toujeo diabetes drug is on track to receive a potential green light from European regulators this week, building on a U.S. regulatory approval awarded on Wednesday. Toujeo is a more potent follow-up to the French drugmaker’s top-selling Lantus insulin product, which accounts for a fifth of group sales, and the new drug is pivotal to Sanofi’s diabetes business as Lantus faces loss of patent protection. A committee of experts at the European Medicines Agency is considering whether to recommend Toujeo at a regular monthly meeting in London, according to the agency’s website. Assuming Toujeo gets a positive opinion, it is likely to be formally approved by the European Commission a couple of months later, allowing Sanofi to launch in its chosen first European markets of Germany and Britain.
Go to Source

Actavis’ superbug antibiotic gets U.S. approval

The U.S. Food and Drug Administration on Wednesday approved the use of Actavis Plc’s antibiotic, Avycaz, to battle drug-resistant bacteria known as superbugs. As a standalone medication, it is used to treat urinary tract infections. Concerns about superbugs have escalated, especially after the UCLA Health System said last week that seven patients were infected with a potentially deadly, drug-resistant strain of the Enterobacteriaceae bacteria, and that more than 100 people might have been exposed to it. Although a number of companies including Roche Holdings AG, Tetraphase Pharmaceuticals Inc, Achaogen Inc and Cempra Inc, are developing drugs for a variety of superbugs, Gabelli & Co analyst Kevin Kedra believes there is room for multiple players.
Go to Source

Chilean girl with cystic fibrosis tells president: Let me die

A 14-year old Chilean girl with cystic fibrosis has asked to be allowed to die in a film she made pleading with President Michelle Bachelet to authorize her euthanasia. In a video that news media said had been uploaded to her Facebook page on Sunday, Valentina Maureira said from her hospital bed: “I am asking to speak urgently to the president because I am tired of living with this sickness and she can authorize the injection to put me to sleep forever.” Cystic fibrosis is a genetic condition that affects the lungs and other organs. Maureira’s brother had died of the disease, her father, Freddy Maureira, told local Radio Bio Bio. A spokeswoman from the Universidad Catolica clinic in Santiago confirmed that Valentina Maureira was a patient at the hospital and said she was stable, with no immediately life-threatening conditions.
Go to Source

1 3 4 5 6 7 53